[1]
B. H. Hameed, “Risedronate as a therapeutic trial post-hysterectomy in premenopausal women to prevent osteoporosis”, Al-Kindy Col. Med. J, vol. 14, no. 1, pp. 4–7, Oct. 2018, doi: 10.47723/kcmj.v14i1.6.